Interview with Kunal Agarwal’s founder and CEO of dope.security, featured in SecurityWeek's Hacker Conversations Series.
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback